Casas R - Search Results

1

More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.

Ludvigsson J, Tavira B, Casas R. Ludvigsson J, et al. Among authors: casas r. N Engl J Med. 2017 Jul 27;377(4):403-5. doi: 10.1056/NEJMc1703468. N Engl J Med. 2017. PMID: 28745988 No abstract available.

2

Poor in vitro maturation and pro-inflammatory cytokine response of dendritic cells in children at genetic risk of type 1 diabetes.

Skarsvik S, Tiittanen M, Lindström A, Casas R, Ludvigsson J, Vaarala O. Skarsvik S, et al. Among authors: casas r. Scand J Immunol. 2004 Dec;60(6):647-52. doi: 10.1111/j.0300-9475.2004.01521.x. Scand J Immunol. 2004. PMID: 15584977 Free article.

3

The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children.

Jonson CO, Hedman M, Karlsson Faresjö M, Casas R, Ilonen J, Ludvigsson J, Vaarala O; ABIS Study Group. Jonson CO, et al. Among authors: casas r. Clin Exp Immunol. 2006 Jul;145(1):48-55. doi: 10.1111/j.1365-2249.2006.03106.x. Clin Exp Immunol. 2006. PMID: 16792673 Free PMC article.

4

Cryopreserved peripheral blood mononuclear cells are suitable for the assessment of immunological markers in type 1 diabetic children.

Axelsson S, Faresjö M, Hedman M, Ludvigsson J, Casas R. Axelsson S, et al. Among authors: casas r. Cryobiology. 2008 Dec;57(3):201-8. doi: 10.1016/j.cryobiol.2008.08.001. Epub 2008 Aug 12. Cryobiology. 2008. PMID: 18761006

5

Impaired CD4 and CD8 T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children.

Hedman M, Faresjö M, Axelsson S, Ludvigsson J, Casas R. Hedman M, et al. Among authors: casas r. Clin Exp Immunol. 2008 Sep;153(3):360-8. doi: 10.1111/j.1365-2249.2008.03720.x. Clin Exp Immunol. 2008. PMID: 18803760 Free PMC article.

6

GAD treatment and insulin secretion in recent-onset type 1 diabetes.

Ludvigsson J, Faresjö M, Hjorth M, Axelsson S, Chéramy M, Pihl M, Vaarala O, Forsander G, Ivarsson S, Johansson C, Lindh A, Nilsson NO, Aman J, Ortqvist E, Zerhouni P, Casas R. Ludvigsson J, et al. Among authors: casas r. N Engl J Med. 2008 Oct 30;359(18):1909-20. doi: 10.1056/NEJMoa0804328. Epub 2008 Oct 8. N Engl J Med. 2008. PMID: 18843118 Free article. Clinical Trial.

7

GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response.

Chéramy M, Skoglund C, Johansson I, Ludvigsson J, Hampe CS, Casas R. Chéramy M, et al. Among authors: casas r. Clin Immunol. 2010 Oct;137(1):31-40. doi: 10.1016/j.clim.2010.06.001. Epub 2010 Jun 30. Clin Immunol. 2010. PMID: 20580618 Free article. Clinical Trial.

8

Immune intervention in children with type 1 diabetes.

Ludvigsson J; Linköping Diabetes Immune Intervention study group. Ludvigsson J, et al. Curr Diab Rep. 2010 Oct;10(5):370-9. doi: 10.1007/s11892-010-0138-y. Curr Diab Rep. 2010. PMID: 20668966

9

Early induction of GAD(65)-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD(65).

Axelsson S, Hjorth M, Akerman L, Ludvigsson J, Casas R. Axelsson S, et al. Among authors: casas r. Diabetes Metab Res Rev. 2010 Oct;26(7):559-68. doi: 10.1002/dmrr.1126. Diabetes Metab Res Rev. 2010. PMID: 20830731

10

GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients.

Hjorth M, Axelsson S, Rydén A, Faresjö M, Ludvigsson J, Casas R. Hjorth M, et al. Among authors: casas r. Clin Immunol. 2011 Jan;138(1):117-26. doi: 10.1016/j.clim.2010.10.004. Epub 2010 Nov 1. Clin Immunol. 2011. PMID: 21044870 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

326 results

Search Page